A Notch-dependent transcriptional hierarchy promotes mesenchymal transdifferentiation in the cardiac cushion

Developmental Dynamics

Volumn 243, Issue 7, 2014, Pages 894-905

  Chang, Alex C Y ^a   Garside, Victoria C ^b,c   Fournier, Michele ^a,c   Smrz, Justin ^a   Vrljicak, Pavle ^b   Umlandt, Patricia ^a,c   Fuller, Megan ^a,c   Robertson, Gordon ^a   Zhao, Yongjun ^a   Tam, Angela ^a   Jones, Steven J M ^a,c   Marra, Marco A ^a,c   Hoodless, Pamela A ^b,c   Karsan, Aly ^a,c  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Cardiac cushion; EMT; Notch

Indexed keywords

CD31 ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; NOTCH RECEPTOR; STAT4 PROTEIN; TRANSCRIPTION FACTOR MSX1; TRANSCRIPTION FACTOR SOX9; VASCULAR ENDOTHELIAL CADHERIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ATRIOVENTRICULAR CANAL; CELL TRANSDIFFERENTIATION; CELL TYPE; CONTROLLED STUDY; DEVELOPMENTAL GENE; EMBRYO; ENDOCARDIUM; EPITHELIAL MESENCHYMAL TRANSITION; EXPLANT; GENE EXPRESSION; GENE REGULATORY NETWORK; GENETIC TRANSCRIPTION; HEART ATRIUM; HEART DEVELOPMENT; HUMAN; HUMAN CELL; MOLECULAR LIBRARY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; WILD TYPE; ANIMAL; CELL LINE; EMBRYOLOGY; ENDOCARDIAL CUSHION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; PHYSIOLOGY; PREGNANCY;

MURINAE; MUS;

ANIMALS; CELL LINE; CELL TRANSDIFFERENTIATION; ENDOCARDIAL CUSHIONS; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE REGULATORY NETWORKS; HUMANS; MALE; MICE; PREGNANCY; RECEPTORS, NOTCH;

EID: 84902543405     PISSN: 10588388     EISSN: 10970177     Source Type: Journal    
DOI: 10.1002/dvdy.24127     Document Type: Article

References (48)

1. Acharya A, Hans CP, Koenig SN, Nichols HA, Galindo CL, Garner HR, Merrill WH, Hinton RB, Garg V. 2011. Inhibitory role of Notch1 in calcific aortic valve disease. PloS One 6:e27743.
2. Akiyama H, Chaboissier MC, Behringer RR, Rowitch DH, Schedl A, Epstein JA, de Crombrugghe B. 2004. Essential role of Sox9 in the pathway that controls formation of cardiac valves and septa. Proc Natl Acad Sci USA 101:6502-6507.
3. Armstrong EJ, Bischoff J. 2004. Heart valve development: endothelial cell signaling and differentiation. Circ Res 95:459-470.
4. Aruga J, Tohmonda T, Homma S, Mikoshiba K. 2002. Zic1 promotes the expansion of dorsal neural progenitors in spinal cord by inhibiting neuronal differentiation. Dev Biol 244:329-341.
5. Baker JH, Lindquist KE, Huxham LA, Kyle AH, Sy JT, Minchinton AI. 2008. Direct visualization of heterogeneous extravascular distribution of trastuzumab in human epidermal growth factor receptor type 2 overexpressing xenografts. Clin Cancer Res 14:2171-2179.
6. Butcher JT, Markwald RR. 2007. Valvulogenesis: the moving target. Phil Trans R Soc Lond B 362:1489-1503.
7. Camenisch TD, Molin DG, Person A, Runyan RB, Gittenberger-de Groot AC, McDonald JA, Klewer SE. 2002. Temporal and distinct TGFbeta ligand requirements during mouse and avian endocardial cushion morphogenesis. Dev Biol 248:170-181.
8. Chang AC, Fu Y, Garside VC, Niessen K, Chang L, Fuller M, Setiadi A, Smrz J, Kyle A, Minchinton A, Marra M, Hoodless PA, Karsan A. 2011. Notch initiates the endothelial-to-mesenchymal transition in the atrioventricular canal through autocrine activation of soluble guanylyl cyclase. Dev Cell 21:288-300.
9. Chen YH, Ishii M, Sucov HM, Maxson RE, Jr. 2008. Msx1 and Msx2 are required for endothelial-mesenchymal transformation of the atrioventricular cushions and patterning of the atrioventricular myocardium. BMC Dev Biol 8:75.
10. Cullum R, Alder O, Hoodless PA. 2011. The next generation: using new sequencing technologies to analyse gene regulation. Respirology 16:210-222.
11. de la Pompa JL, Epstein JA. 2012. Coordinating tissue interactions: Notch signaling in cardiac development and disease. Dev Cell 22:244-254.
12. Del Monte G, Grego-Bessa J, Gonzalez-Rajal A, Bolos V, De La Pompa JL. 2007. Monitoring Notch1 activity in development: evidence for a feedback regulatory loop. Dev Dyn 236:2594-2614.
13. Dennis G, Jr., Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. 2003. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 4:P3.
14. Donovan J, Kordylewska A, Jan YN, Utset MF. 2002. Tetralogy of fallot and other congenital heart defects in Hey2 mutant mice. Curr Biol 12:1605-1610.
15. Dumont DJ, Gradwohl G, Fong GH, Puri MC, Gertsenstein M, Auerbach A, Breitman ML. 1994. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev 8:1897-1909.
16. Eisenberg LM, Markwald RR. 1995. Molecular regulation of atrioventricular valvuloseptal morphogenesis. Circ Res 77:1-6.
17. Eldadah ZA, Hamosh A, Biery NJ, Montgomery RA, Duke M, Elkins R, Dietz HC. 2001. Familial Tetralogy of Fallot caused by mutation in the jagged1 gene. Human Mol Genet 10:163-169.
18. Fischer A, Schumacher N, Maier M, Sendtner M, Gessler M. 2004. The Notch target genes Hey1 and Hey2 are required for embryonic vascular development. Genes Dev 18:901-911.
19. Fischer A, Steidl C, Wagner TU, Lang E, Jakob PM, Friedl P, Knobeloch KP, Gessler M. 2007. Combined loss of Hey1 and HeyL causes congenital heart defects because of impaired epithelial to mesenchymal transition. Circ Res 100:856-863.
20. Fu Y, Chang A, Chang L, Niessen K, Eapen S, Setiadi A, Karsan A. 2009. Differential regulation of transforming growth factor beta signaling pathways by Notch in human endothelial cells. J Biol Chem 284:19452-19462.
21. Fu Y, Chang AC, Fournier M, Chang L, Niessen K, Karsan A. 2011. RUNX3 maintains the mesenchymal phenotype after termination of the Notch signal. J Biol Chem 286:11803-11813.
22. Garg V, Muth AN, Ransom JF, Schluterman MK, Barnes R, King IN, Grossfeld PD, Srivastava D. 2005. Mutations in NOTCH1 cause aortic valve disease. Nature 437:270-274.
23. Garside VC, Chang AC, Karsan A, Hoodless PA. 2013. Co-ordinating Notch, BMP, and TGF-beta signaling during heart valve development. Cell Mol Life Sci 70:2899-2917.
24. Gotea V, Ovcharenko I. 2008. DiRE: identifying distant regulatory elements of co-expressed genes. Nucleic Acids Res 36:W133-139.
25. Gustafsson MV, Zheng X, Pereira T, Gradin K, Jin S, Lundkvist J, Ruas JL, Poellinger L, Lendahl U, Bondesson M. 2005. Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev Cell 9:617-628.
26. Hinton RB, Jr., Lincoln J, Deutsch GH, Osinska H, Manning PB, Benson DW, Yutzey KE. 2006. Extracellular matrix remodeling and organization in developing and diseased aortic valves. Circ Res 98:1431-1438.
27. Hoffman JI, Kaplan S. 2002. The incidence of congenital heart disease. J Am Coll Cardiol 39:1890-1900
28. Iso T, Kedes L, Hamamori Y. 2003. HES and HERP families: multiple effectors of the Notch signaling pathway. J Cell Physiol 194:237-255.
29. Khattra J, Delaney AD, Zhao Y, Siddiqui A, Asano J, McDonald H, Pandoh P, Dhalla N, Prabhu AL, Ma K, Lee S, Ally A, Tam A, Sa D, Rogers S, Charest D, Stott J, Zuyderduyn S, Varhol R, Eaves C, Jones S, Holt R, Hirst M, Hoodless PA, Marra MA. 2007. Large-scale production of SAGE libraries from microdissected tissues, flow-sorted cells, and cell lines. Genome Res 17:108-116.
30. Li L, Krantz ID, Deng Y, Genin A, Banta AB, Collins CC, Qi M, Trask BJ, Kuo WL, Cochran J, Costa T, Pierpont ME, Rand EB, Piccoli DA, Hood L, Spinner NB. 1997. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nature Genet 16:243-251.
31. Lincoln J, Kist R, Scherer G, Yutzey KE. 2007. Sox9 is required for precursor cell expansion and extracellular matrix organization during mouse heart valve development. Dev Biol 305:120-132.
32. Longabaugh WJ, Davidson EH, Bolouri H. 2005. Computational representation of developmental genetic regulatory networks. Dev Biol 283:1-16.
33. Meadows KN, Iyer S, Stevens MV, Wang D, Shechter S, Perruzzi C, Camenisch TD, Benjamin LE. 2009. Akt promotes endocardial-mesenchyme transition. J Angiogen Res 1:2.
34. Mukherjee T, Kim WS, Mandal L, Banerjee U. 2011. Interaction between Notch and Hif-alpha in development and survival of Drosophila blood cells. Science 332:1210-1213.
35. Niessen K, Fu Y, Chang L, Hoodless PA, McFadden D, Karsan A. 2008. Slug is a direct Notch target required for initiation of cardiac cushion cellularization. J Cell Biol 182:315-325.
36. Noseda M, McLean G, Niessen K, Chang L, Pollet I, Montpetit R, Shahidi R, Dorovini-Zis K, Li L, Beckstead B, Durand RE, Hoodless PA, Karsan A. 2004. Notch activation results in phenotypic and functional changes consistent with endothelial-to-mesenchymal transformation. Circ Res 94:910-917.
37. Noseda M, Fu Y, Niessen K, Wong F, Chang L, McLean G, Karsan A. 2006. Smooth Muscle alpha-actin is a direct target of Notch/CSL. Circ Res 98:1468-1470.
38. Oda T, Elkahloun AG, Pike BL, Okajima K, Krantz ID, Genin A, Piccoli DA, Meltzer PS, Spinner NB, Collins FS, Chandrasekharappa SC. 1997. Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nature Genet 16:235-242.
39. Pierpont ME, Basson CT, Benson DW, Jr., Gelb BD, Giglia TM, Goldmuntz E, McGee G, Sable CA, Srivastava D, Webb CL. 2007. Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 115:3015-3038.
40. Restivo A, Piacentini G, Placidi S, Saffirio C, Marino B. 2006. Cardiac outflow tract: a review of some embryogenetic aspects of the conotruncal region of the heart. Anat Rec A Discov Mol Cell Evol Biol 288:936-943.
41. Sahlgren C, Gustafsson MV, Jin S, Poellinger L, Lendahl U. 2008. Notch signaling mediates hypoxia-induced tumor cell migration and invasion. Proc Natl Acad Sci USA 105:6392-6397.
42. Timmerman LA, Grego-Bessa J, Raya A, Bertran E, Perez-Pomares JM, Diez J, Aranda S, Palomo S, McCormick F, Izpisua-Belmonte JC, de la Pompa JL. 2004. Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. Genes Dev 18:99-115.
43. Vesely I. 1998. The role of elastin in aortic valve mechanics. J Biomechan 31:115-123.
44. Vrljicak P, Chang AC, Morozova O, Wederell ED, Niessen K, Marra MA, Karsan A, Hoodless PA. 2010. Genomic analysis distinguishes phases of early development of the mouse atrio-ventricular canal. Physiol Genom 40:150-157.
45. Vrljicak P, Cullum R, Xu E, Chang AC, Wederell ED, Bilenky M, Jones SJ, Marra MA, Karsan A, Hoodless PA. 2012. Twist1 transcriptional targets in the developing atrio-ventricular canal of the mouse. PloS One 7:e40815.
46. Wederell ED, Bilenky M, Cullum R, Thiessen N, Dagpinar M, Delaney A, Varhol R, Zhao Y, Zeng T, Bernier B, Ingham M, Hirst M, Robertson G, Marra MA, Jones S, Hoodless PA. 2008. Global analysis of in vivo Foxa2-binding sites in mouse adult liver using massively parallel sequencing. Nucleic Acids Res 36:4549-4564.
47. Zeisberg M, Neilson EG. 2009. Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 119:1429-1437.
48. Zheng X, Linke S, Dias JM, Gradin K, Wallis TP, Hamilton BR, Gustafsson M, Ruas JL, Wilkins S, Bilton RL, Brismar K, Whitelaw ML, Pereira T, Gorman JJ, Ericson J, Peet DJ, Lendahl U, Poellinger L. 2008. Interaction with factor inhibiting HIF-1 defines an additional mode of cross-coupling between the Notch and hypoxia signaling pathways. Proc Natl Acad Sci USA 105:3368-3373.